Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction
Clinical trial NCT04944706 · COMPLETED
Trial details
- NCT number
- NCT04944706
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-27
- Primary completion
- 2024-12-19
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.